Active Pharmaceutical Ingredients

Intrexon's synthetic biology technology is helping to drive a new era of more affordable drugs.  Utilizing our robust microbial-based expression systems, Intrexon through collaboration is focusing on the development of consistent, scalable, and cost-effective processes for targeted APIs.  By utilizing pathway development, as well as strain and fermentation optimization to advance API production processes, Intrexon's approach replaces complex, multistep chemical synthesis of APIs and also avoids resource-intensive isolation from animals and plants, leading to improved process economics for APIs.